DURHAM, N.C.--(BUSINESS WIRE)--Tecan is collaborating with tissue engineering researchers at the University of Zurich to develop a novel, automated system for propagation of quality controlled cells that will be suitable for use in regenerative medicine therapies, such as intervertebral disc implants. The project is funded by the CTI, the Swiss Confederation’s innovation promotion agency.
